Lenvatinib Mesylate and Ustekinumab Intravenous Infusion
Determining the interaction of Lenvatinib Mesylate and Ustekinumab Intravenous Infusion and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
Generic Name: ustekinumab
Brand name: Stelara, Stelara PFS
Synonyms: Ustekinumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib Mesylate-Ustekinumab Subcutaneous
- Lenvatinib Mesylate-Ustekinumab Subcutaneous Injection
- Lenvatinib Mesylate-Ustell
- Lenvatinib Mesylate-UTA
- Lenvatinib Mesylate-UTA Capsules
- Lenvatinib Mesylate-UTAC tablets
- Ustekinumab Intravenous Infusion-Lenvima
- Ustekinumab Intravenous Infusion-Lenvima (14 MG Daily Dose)
- Ustekinumab Intravenous Infusion-Lenvima (18 MG Daily Dose)
- Ustekinumab Intravenous Infusion-Lenvima (20 MG Daily Dose)
- Ustekinumab Intravenous Infusion-Lenvima (24 MG Daily Dose)
- Ustekinumab Intravenous Infusion-Lenvima (8 MG Daily Dose)